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Unlike the ascending aorta and aortic arch, there was no asso-
ciation between the descending aorta and APOE*E4. Potential
reasons for this include the fact that the progression of atheroscle-
rosis in the aorta is influenced by the flow dynamics and wall shear
stress within the segments of the aorta.4 For example, the higher
ejection velocity in the ascending aorta might limit formation of
plaques in this region. More importantly, the influence of age on
atherosclerosis is very strong, with an incidence rising steadily
with age.5 Because patients undergoing cardiac surgery are in-
creasingly elderly, the effect of APOE*E4 might be masked by the
dominating influence of age on atherosclerosis, particularly in the
descending aorta.
Limitations to our study include the fact that our technique uses
a 2-dimensional, rather than 3-dimensional, image of a specific
aortic segment. Nevertheless, the percentage of atheroma method
that we used does at least account for total plaque area that can be
visualized. Finally, epiaortic imaging is a more sensitive measure
of assessing plaque in the ascending aorta, and it is possible that a
greater degree of atherosclerosis might have been detected, with its
use potentially improving the link between atheroma burden and
the APOE*E4 allele.
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Systemic allergic reaction to the percutaneous patent foramen ovale
occluder
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Transcatheter occlusion of an atrial septal defect or patentforamen ovale (PFO) has become an effective and lessinvasive alternative to cardiac surgery.1 A number ofcomplications have been recognized.2 However, hyper-
sensitivity or allergic reaction to the device itself has been not
reported.
We treated a patient who had a systemic allergic reaction to the
percutaneous PFO occluder. The case is described, and the thera-
peutic implication is discussed.
Clinical Summary
A 37-year-old woman with a PFO was admitted to our institution
for transcatheter occlusion of her PFO. She had an episode of
paradoxical cerebral embolism 1 year previously, and anticoagu-
lation therapy with phenprocoumon had been initiated. Despite
anticoagulation therapy, the patient had a transient ischemic attack
6 months before admission. She was offered the option of trans-
catheter occlusion of her PFO, and she agreed to the procedure.
The patient had slight exertional dyspnea (New York Heart Asso-
ciation class I-II) but had no body weight change or fever at the
time of admission.
Transvenous occlusion of the PFO was performed with a PFO-
Star device (Cardia Inc, Burnsville, Minn) by using a 30-mm
umbrella under transesophageal echocardiographic guidance. The
postinterventional studies showed that the position of the device
was satisfactory, and there was no residual shunt.
Two months after PFO occlusion, the patient began having
dyspnea, a temperature of 38°C, and dependent edema. Endocar-
ditis or infection of the device was suspected, and she was referred
back to our institution. Laboratory examination revealed a white
blood cell count of 8800 mg/dL (granulocytes, 51.9%; lympho-
cytes, 31.4%; monocytes, 9.8%; eosinophils, 5.7%; and basophils,
1.2%), a hemoglobin concentration of 14.5 g/dL, a hematocrit
level of 43.2%, a platelet count of 256,000/dL, and a C-reactive
protein concentration of 0.8 mg/dL; other biochemical indices
were within normal limits. Echocardiography with color Doppler
scanning showed no residual shunt, no findings suggestive of
intracardiac vegetation, and good cardiac function. Blood cultures
were performed several times, but each showed no growth. Her
history was significant for allergic reactions to some medications
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and an episode of allergic asthma. With high levels of immuno-
globulin E (144 U/mL; normal range, 0-100 U/mL) and eosino-
philic cations protein (29 g/mL; normal rangem 2.3-12.0 g/
mL), we assumed the patient was having a hypersensitivity
reaction to the PFO occluder. Skin patch testing was performed
with nitinol, the primary component of the device, and results were
positive in both the early and late phases.
Because the high-grade fever and edema persisted, the patient
agreed to explantation of the device. Four months after transcath-
eter PFO occlusion, the device was removed surgically, and PFO
closure with an autologous pericardial patch was performed during
extracoreporeal cardiopulmonary bypass. Intraoperative examina-
tion showed that the device appeared to be functioning properly
(Figure 1). Pathologic examination of the device showed nonspe-
cific inflammation with no evidence of infection. The patient
recovered uneventfully and is doing well 1 year postoperatively.
Discussion
A PFO might result in recurrent paradoxical embolism, leading to
stroke or occlusion of the peripheral artery.1 Recently, transcath-
eter closure has been offered to these patients as an effective and
less invasive therapeutic option. However, these procedures are
not free of potential problems. Reported complications include
cerebral embolism, cardiac perforation, malpositioning of the de-
vice with residual shunt, vascular trauma, thrombus formation on
the device, and interference with atrioventricular valve function.2
This is the first report of hypersensitivity to the device itself.
Nitinol is a shape-memory alloy with good biocompatibility.
Nitinol is composed of nickel (55%) and titanium (45%) and is
suitable for the fabrication of endovascular and intracardiac de-
vices. Recently, it has been used more widely for other types of
interventional procedures as well.3 On the other hand, it is widely
known that nickel is highly allergenic. Recently Ko¨ster and col-
leagues4 reported a higher frequency of coronary in-stent resteno-
sis in patients with delayed-type hypersensitivity to nickel than in
patients without sensitization to nickel. They recommended that all
patients who are candidates for coronary stent implantation should
be asked specifically about previous or present metal allergies.
In our patient the clinical course and positive skin patch test
result led to the presumptive diagnosis of hypersensitivity to the
device. However, pathologic examination showed only nonspecific
inflammation, without infiltration by eosinophils. Thus, we cannot
say unequivocally that the patient had an allergic reaction to the
device. The positive result of the skin patch test is not adequate to
establish hypersensitivity. However, in conjunction with the clin-
ical course (ie, the persistent symptoms that resolved with removal
of the device), a hypersensitivity reaction is the most likely diag-
nosis.
Systemic allergic reaction to the PFO occluder might not be
common, but the potential risk of nickel toxicity should not be
ignored.5 The value of preoperative skin patch testing for metals in
all patients is controversial, but testing is likely justified in patients
with a history of allergic reactions. Regardless of results, however,
the risks and benefits of therapeutic options with metal-containing
intracardial or endovascular devices in such patients must be
considered carefully.
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Figure 1. Intraoperative view of the percutaneous PFO occluder.
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